We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSDO
1851
DELISTED
Presidio, Inc. Common Stock
PSDO
-62,478
Closed -$925K
ROAN
1852
DELISTED
Roan Resources, Inc.
ROAN
-17,514
Closed -$107K
SEMG
1853
DELISTED
SEMGROUP CORPORATION
SEMG
-2,200
Closed -$32K
CBM
1854
DELISTED
Cambrex Corporation
CBM
-600
Closed -$23K
MCRN
1855
DELISTED
Milacron Holdings Corp.
MCRN
-1,023
Closed -$12K
DF
1856
DELISTED
Dean Foods Company
DF
-16,300
Closed -$49K
STNL
1857
DELISTED
Sentinel Energy Services Inc. Class A Common Stock
STNL
-15
Closed
LTXB
1858
DELISTED
LegacyTexas Financial Group Inc
LTXB
-15,581
Closed -$583K
CTWS
1859
DELISTED
Connecticut Water Service Inc
CTWS
-360
Closed -$25K
VSM
1860
DELISTED
Versum Materials, Inc.
VSM
-866
Closed -$44K
BID
1861
DELISTED
Sotheby's
BID
-41,758
Closed -$1.57M
NRE
1862
DELISTED
NorthStar Realty Europe Corp.
NRE
-700
Closed -$12K
SFLY
1863
DELISTED
Shutterfly, Inc.
SFLY
-26,880
Closed -$1.09M
MSL
1864
DELISTED
Midsouth Bancorp, Inc.
MSL
-7,061
Closed -$81K
CHSP
1865
DELISTED
Chesapeake Lodging Trust
CHSP
-14,364
Closed -$399K
BT
1866
DELISTED
BT Group plc (ADR)
BT
-3,842
Closed -$57K
APC
1867
DELISTED
Anadarko Petroleum
APC
-575,902
Closed -$26.2M
CTRL
1868
DELISTED
Control4 Corporation
CTRL
-7,634
Closed -$129K
ARRY
1869
DELISTED
Array Biopharma Inc
ARRY
-2,554,381
Closed -$62.3M
AMID
1870
DELISTED
American Midstream Partners, LP
AMID
-31,452
Closed -$163K
HIFR
1871
DELISTED
InfraREIT, Inc.
HIFR
-45,320
Closed -$950K
BRS
1872
DELISTED
Bristow Group, Inc.
BRS
-200
Closed
CMTA
1873
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
-1,685
Closed -$44K
RDC
1874
DELISTED
Rowan Companies Plc
RDC
-37
Closed
TEUM
1875
DELISTED
Pareteum Corporation
TEUM
-1,285,415
Closed -$5.85M

Similar funds

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.